For decades clinicians and public‑health experts have known what it takes to prevent most heart attacks and strokes caused by high blood pressure: accurate measurement, affordable medicines, clear treatment steps and systems that keep patients on therapy. But translating that knowledge into reliable care at scale in primary health systems has proved difficult.
One clear plan, many places
The World Health Organization’s Global HEARTS Initiative promotes a compact, evidence‑based technical package that packages those components into a practical playbook for primary care: simple, drug‑and‑dose treatment protocols; access to quality assured medicines and blood‑pressure monitors; team‑based care; patient‑centered community services; and monitoring systems to track progress. Countries that adopt the package tailor the protocol to local essential‑medicines lists but keep the same operational approach so clinics can identify, treat and follow patients reliably. ([who.int](https://www.who.int/initiatives/global-hearts-initiative?utm_source=openai))
Real results, not just plans
The HEARTS approach is more than guidance on a shelf. A regional case series compiled by the Pan American Health Organization (PAHO) describes 18 countries in the Americas that have adopted HEARTS and are actively scaling protocol‑based hypertension care; together, several regional programs now reach millions of people. Early national and subnational programs report measurable gains in how many patients achieve blood‑pressure control. ([paho.org](https://www.paho.org/en/node/74785?utm_source=openai))
Independent analyses find that HEARTS‑style programs can be implemented across low‑ and middle‑income countries and that optimizing procurement, task‑sharing and prescription habits can sharply reduce the cost of treating a person with hypertension — in some modeling, to under US$10 per patient per year — while expanding coverage. That cost picture helps explain why governments and funders are moving from pilots to broader scale‑up. ([jacc.org](https://www.jacc.org/doi/10.1016/j.jacc.2023.08.043?utm_source=openai))
Country examples: scale and evaluation
India’s long‑running Hypertension Control Initiative — one of the largest implementations of HEARTS principles — grew from pilot districts to many states and, by mid‑2023, had enrolled millions of patients for structured treatment and follow‑up under standardized protocols and simplified medicine lists. Analyses of that expansion have become an important proof of concept for other large health systems considering national scale‑up. ([nature.com](https://www.nature.com/articles/s41591-025-03652-4?utm_source=openai))
In Bangladesh, a quasi‑experimental evaluation of HEARTS implementation at primary‑care facilities found that clinics using the package achieved larger reductions in uncontrolled blood pressure than matched usual‑care sites. That kind of real‑world evidence — randomized trials are rare at service‑delivery scale — strengthens the case that standardized treatment protocols, better measurement and systems to keep patients in care translate into better blood‑pressure control. ([heart.bmj.com](https://heart.bmj.com/content/early/2024/07/16/heartjnl-2024-324253?versioned=true&utm_source=openai))
Why the approach works
Public‑health experts point to several features that make HEARTS effective in diverse settings. First, standardized protocols reduce clinical uncertainty and therapeutic inertia: clinicians and non‑physician providers know which medicines to start and when to intensify. Second, a reliable supply of quality generic medicines and longer refills for stable patients improve adherence. Third, team‑based care — with nurses, pharmacists and community health workers supporting follow‑up — expands capacity without relying on scarce physicians. Finally, simple information systems let managers spot gaps in detection, treatment and control and target support. Multiple program reviews and technical reports highlight these same elements as the backbone of success. ([who.int](https://www.who.int/initiatives/global-hearts-initiative?utm_source=openai))
Potential population impact
Modeling work tied to HEARTS implementation shows that improving population blood‑pressure control at scale can prevent large numbers of cardiovascular events and deaths over decades and be highly cost‑effective. Where programs accelerate access and control, health systems can expect to reduce future strokes and ischemic heart disease — the very outcomes that drive excessive disability and health costs in many countries. ([jacc.org](https://www.jacc.org/doi/10.1016/j.jacadv.2025.102412?utm_source=openai))
Challenges remain — but the path is clearer
Adopting standardized protocols does not erase hurdles. Countries still face supply‑chain shocks, competing budget priorities, workforce shortages and the need to reach people who rarely visit clinics. Some regions lag behind others in awareness, measurement quality and information systems. But the growing body of program‑level evidence and the increasing number of countries committed to HEARTS give health leaders practical tools and tested operational examples to borrow from when designing their own scale‑up. ([who.int](https://www.who.int/initiatives/global-hearts-initiative?utm_source=openai))
What this means for patients
For someone with high blood pressure, the difference looks simple and concrete: reliable measurement, a short list of effective generic medicines and a clinic that proactively contacts patients for refills and follow‑up. Those ingredients — widely available in high‑income settings for decades — are now being packaged and delivered in more low‑ and middle‑income health systems. When that happens at scale, more people control their blood pressure and fewer people face the sudden, life‑altering event of a stroke or heart attack.
The global story is not one of instant triumph but of practical progress: a tested technical package, growing national commitments, peer‑reviewed evaluations and modeling that together point to a feasible route for preventing cardiovascular disease at population scale. For policymakers and clinicians trying to lower the toll of hypertension, that is welcome, measurable good news. ([who.int](https://www.who.int/initiatives/global-hearts-initiative?utm_source=openai))
